Authors:
JAGER PL
FRANSSEN EJF
KOOL W
SZABO BG
HOEKSTRA HJ
GROEN HJM
DEVRIES EGE
VANIMHOFF GW
VAALBURG W
PIERS DA
Citation: Pl. Jager et al., FEASIBILITY OF TUMOR IMAGING USING L-3-[IODINE-123]-IODO-ALPHA-METHYL-TYROSINE IN EXTRACRANIAL TUMORS, The Journal of nuclear medicine, 39(10), 1998, pp. 1736-1743
Authors:
DOORDUIJN JK
VANDERHOLT B
BREED WPM
VANDERHEM KG
VANIMHOFF GW
KRAMER MHH
KOOY MV
VANOERS MHJ
OSSENKOPPELE GJ
RICHEL DJ
ROOZENDAAL KJ
VANTVEER MB
VERDONCK LF
VERHOEF G
WIJERMANS PW
SONNEVELD P
Citation: Jk. Doorduijn et al., EFFICACY OF STANDARD CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH POOR-RISK NON-HODGKINS-LYMPHOMA (NHL), British Journal of Haematology, 102(1), 1998, pp. 149-149
Authors:
DAENEN S
VANIMHOFF GW
VANDENBERG E
DEKAM PJ
HAAXMAREICHE H
VELLENGA E
SMIT JW
HALIE RM
Citation: S. Daenen et al., IMPROVED OUTCOME OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA BY MODERATELY INTENSIFIED CHEMOTHERAPY WHICH INCLUDES A PREINDUCTION COURSE FOR RAPID TUMOR REDUCTION - PRELIMINARY-RESULTS ON 66 PATIENTS, British Journal of Haematology, 100(2), 1998, pp. 273-282
Authors:
VANDENBERG E
ROSATI S
NOORDHOEK L
VANIMHOFF GW
POPPEMA S
Citation: E. Vandenberg et al., CYTOGENETIC, HISTOLOGIC AND IMMUNOPHENOTYPIC EVIDENCE FOR TUMOR PROGRESSION IN 2 LYMPH-NODE BIOPSIES OBTAINED AT THE SAME TIME OF A PATIENTWITH FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 3961-3961
Authors:
GROOT CAUD
OKHUIJSEN SY
HAGENBEEK A
HUIJGENS PC
VANIMHOFF GW
LOWENBERG B
VERDONCK LF
RUTTEN FFH
Citation: Caud. Groot et al., COSTS OF INTRODUCING AUTOLOGOUS BMT IN THE TREATMENT OF LYMPHOMA AND ACUTE-LEUKEMIA IN THE NETHERLANDS, Bone marrow transplantation, 15(4), 1995, pp. 605-610
Authors:
VERDONCK LF
VANPUTTEN WLJ
HAGENBEEK A
SCHOUTEN HC
SONNEVELD P
VANIMHOFF GW
KLUINNELEMANS HC
RAEMAEKERS JMM
VANOERS RHJ
HAAK HL
SCHOTS R
DEKKER AW
DEGAST GC
LOWENSBERG B
Citation: Lf. Verdonck et al., COMPARISON OF CHOP CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SLOWLY RESPONDING PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 332(16), 1995, pp. 1045-1051
Authors:
VANKAMP H
VANIMHOFF GW
DEWOLF JTM
SMIT JW
HALIE MR
VELLENGA E
Citation: H. Vankamp et al., THE EFFECT OF CYCLOSPORINE ON HEMATOLOGICAL PARAMETERS IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, British Journal of Haematology, 89(1), 1995, pp. 79-82
Authors:
DAENEN S
VANIMHOFF GW
HAAXMAREICHE H
VELLENGA E
DEWOLF JTM
HALIE MR
Citation: S. Daenen et al., OUTCOME OF A HYBRID CHEMOTHERAPY REGIMEN WITH MEDIASTINAL IRRADIATIONIN LEUKEMIC T-LYMPHOBLASTIC LYMPHOMA, Blood, 86(10), 1995, pp. 3005-3005
Authors:
RAEMAEKERS JMM
VANIMHOFF GW
VERDONCK LF
HESSELS JA
FIBBE WE
Citation: Jmm. Raemaekers et al., THE TOLERABILITY OF CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 AFTER DHAP CHEMOTHERAPY IN PATIENTS WITH RELAPSED MALIGNANT-LYMPHOMA -A PHASE-I STUDY, Annals of hematology, 67(4), 1993, pp. 175-181
Authors:
FOGTELOO AJ
SMID WM
KOK T
VANDERMEER J
VANIMHOFF GW
DAENEN S
Citation: Aj. Fogteloo et al., SUCCESSFUL TREATMENT OF VENOOCCLUSIVE DISEASE OF THE LIVER WITH UROKINASE IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Leukemia, 7(5), 1993, pp. 760-763
Citation: Ftm. Peters et al., IS CHEMOTHERAPY ASSOCIATED WITH DEVELOPMENT OF BARRETT-ESOPHAGUS, Digestive diseases and sciences, 38(5), 1993, pp. 923-926